NEW YORK — Swedish sample collection company Capitainer said on Wednesday that it has secured SEK 21 million ($2.0 million) in funding from life sciences investment firm Sciety and its affiliate Sciety Venture Partners.
The financing comes just months after Capitainer raised $7.2 million in a Series A financing round that included Werfen's investment arm We Venture Capital, Sciety, and Sciety Venture Partners.
Capitainer has developed self-sampling technology allows patients to use a card to collect fingertip blood samples that can be sent through standard mail without needing special packaging or refrigeration. It plans to use the new funding to continue boosting its production capabilities and expand sales efforts in Europe and the US.
"This strategic capital boost allows us to fast-track our expansion, with a particular focus on enhancing our presence in the USA, where we recently inaugurated our own laboratory," Capitainer CEO Christopher Aulin said in a statement.